-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics FY2026 Revenue expected to be more than $625.00M vs $629.23M Est

Benzinga·05/07/2025 20:16:02
Listen to the news
ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $625.00M vs $629.23M Est